Filana Therapeutics, Inc. (FLNA) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Filana Therapeutics, Inc. (FLNA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Filana Therapeutics, Inc., the average estimate for 2030 earnings per share is −$0.48; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Filana Therapeutics, Inc. (FLNA) forecast — frequently asked questions
What are analysts forecasting for Filana Therapeutics, Inc.'s earnings?
The average analyst estimate for Filana Therapeutics, Inc. (FLNA) earnings per share in 2030 is -0.48, with individual estimates between -0.48 and -0.48.
How much revenue is Filana Therapeutics, Inc. expected to make?
Analysts forecast Filana Therapeutics, Inc. (FLNA) revenue of $72.83M in 2030, based on 1 published estimates.
How many analysts cover FLNA?
2 analysts contribute estimates for Filana Therapeutics, Inc. (FLNA). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.